​

I-Mab (IMAB) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

IMAB Stock Rating

I-Mab stock's rating consensus is Buy, based on 10 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 10 0 10 Strong Sell Sell Hold Buy Strong Buy

IMAB Price Target Upside V Benchmarks

TypeNameUpside
StockI-Mab-
SectorHealthcare Stocks 18.80%
IndustryBiotech Stocks 54.28%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.87$1.87$1.87
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 2523---5
Jun, 2523---5
May, 2522---4
Apr, 2522---4
Mar, 2522---4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 16, 2024Piper SandlerOverweightOverweighthold
Mar 18, 2024Piper SandlerOverweightOverweighthold
Aug 17, 2022NeedhamBuyBuyhold
Jun 07, 2022Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

$-35 $-26 $-17 $-8 $1 $10 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$8.07$-30.69$-31.75$-16.53-----
Avg Forecast$3.46$-15.72$-14.70$-11.53$-0.95$-3.44$-2.20$-5.42$-5.86
High Forecast$3.46$-15.72$-14.70$-10.06$-0.50$-2.98$-0.87$-5.42$-5.86
Low Forecast$3.46$-15.72$-14.70$-13.00$-1.38$-3.87$-3.52$-5.42$-5.86
Surprise %133.24%95.23%115.99%43.37%-----

Revenue Forecast

$-5B $-1B $3B $7B $11B $15B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.54B$88.03M$-221.56M$27.64M-----
Avg Forecast$1.19B$495.15M$312.90M$26.27M$5.47M$5.49M$10.98M$21.96M$21.96M
High Forecast$1.19B$10.99B$312.90M$43.63M$5.47M$5.49M$10.98M$21.96M$21.96M
Low Forecast$1.19B$100.37M$312.90M$17.56M$5.47M$5.49M$10.98M$21.96M$21.96M
Surprise %29.16%-82.22%-170.81%5.24%-----

Net Income Forecast

$-3B $-2B $-1B $-700M $-100M $500M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$470.92M$-2.33B$-2.41B$-1.47B-----
Avg Forecast$288.22M$-1.31B$-1.22B$-2.21B$-180.04M$-656.08M$-420.33M$-1.04B$-1.12B
High Forecast$288.22M$-1.31B$-1.22B$-1.93B$-95.60M$-570.72M$-165.92M$-1.04B$-1.12B
Low Forecast$288.22M$-1.31B$-1.22B$-2.49B$-264.48M$-741.45M$-674.74M$-1.04B$-1.12B
Surprise %63.39%78.22%97.13%-33.60%-----

IMAB Forecast FAQ

Is I-Mab stock a buy?

I-Mab stock has a consensus rating of Buy, based on 10 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that I-Mab is a favorable investment for most analysts.

What is I-Mab's price target?

I-Mab's price target, set by 10 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $1.87.

How does I-Mab stock forecast compare to its benchmarks?

I-Mab's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (18.80%) and underperforming the biotech stocks industry (54.28%).

What is the breakdown of analyst ratings for I-Mab over the past three months?

  • July 2025: 40.00% Strong Buy, 60.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • June 2025: 40.00% Strong Buy, 60.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is I-Mab’s EPS forecast?

I-Mab's average annual EPS forecast for its fiscal year ending in December 2024 is $-0.95, marking a -94.25% decrease from the reported $-16.53 in 2023. Estimates for the following years are $-3.44 in 2025, $-2.2 in 2026, $-5.42 in 2027, and $-5.86 in 2028.

What is I-Mab’s revenue forecast?

I-Mab's average annual revenue forecast for its fiscal year ending in December 2024 is $5.47M, reflecting a -80.20% decrease from the reported $27.64M in 2023. The forecast for 2025 is $5.49M, followed by $10.98M for 2026, $21.96M for 2027, and $21.96M for 2028.

What is I-Mab’s net income forecast?

I-Mab's net income forecast for the fiscal year ending in December 2024 stands at $-180M, representing a -87.72% decrease from the reported $-1.466B in 2023. Projections indicate $-656M in 2025, $-420M in 2026, $-1.037B in 2027, and $-1.121B in 2028.